{
  "paper_metadata": {
    "pmid": "31336956",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1670T>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age 33",
        "phenotype": "early onset breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "SA22-18",
          "age_at_evaluation": 33,
          "age_at_onset": null,
          "age_at_diagnosis": 33,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "early onset breast cancer",
          "evidence_sentence": "Among the eleven patients with early onset breast cancer, we identified three women (SA22-18, MV55-17 and LA89-17 in Table 1) carrying known PVs (the c.3607C>T and the c.1016delA mutations in BRCA1 and the c.1670T>G in BRCA2)."
        }
      ],
      "functional_data": {
        "summary": "Identified as a pathogenic variant.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6590_6591insA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age 36",
        "phenotype": "early onset breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "FG65-19",
          "age_at_evaluation": 36,
          "age_at_onset": null,
          "age_at_diagnosis": 36,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "early onset breast cancer",
          "evidence_sentence": "This alteration was identified in an early onset breast cancer patient (patient FG65-19 in Table 1)."
        }
      ],
      "functional_data": {
        "summary": "Identified as a pathogenic variant.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4899_4902delCTTT",
      "protein_notation": "p.Phe1634Ter",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age 50",
        "phenotype": "bilateral breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "CG98-18",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "bilateral breast cancer",
          "evidence_sentence": "The small frameshift deletion c.4899_4902delCTTT, leading to premature protein termination at codon 1634 (p.Phe1634Ter) within exon 11, was detected in a patient with bilateral breast cancer (patient CG98-18 in Table 1)."
        }
      ],
      "functional_data": {
        "summary": "Disruption of crucial functional domains producing a premature truncated non-functional protein.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7225C>T",
      "protein_notation": "p.Pro2409Ser",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "female, age 36",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "OA78-18",
          "age_at_evaluation": 36,
          "age_at_onset": null,
          "age_at_diagnosis": 36,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The BRCA2 c.7225C>T (p.Pro2409Ser) variant was detected in a young woman (patient OA78-18 in Table 1) with breast cancer."
        }
      ],
      "functional_data": {
        "summary": "Classified as VUS but with potential pathogenicity.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5971G>A",
      "protein_notation": "p.Ala1991Thr",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": 1,
        "demographics": "male, age 50",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "PM55-16",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": 50,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The BRCA2 c.5971G>A (p.Ala1991Thr) variant, detected in a man with breast cancer at the age of 50 years (patient PM55-16 in Table 1)."
        }
      ],
      "functional_data": {
        "summary": "Considered likely benign with no significant clinical importance.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "weak",
      "source_location": "Results, paragraph 4",
      "additional_notes": "",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9219C>T",
      "protein_notation": "p.Asp3073Asp",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "female, age 50",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "MR52-18",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The last novel variant detected in BRCA2 gene was the c.9219C>T (p.Asp3073Asp) (patient MR52-18 in Table 1)."
        }
      ],
      "functional_data": {
        "summary": "Considered a VUS with no significant clinical importance.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "weak",
      "source_location": "Results, paragraph 4",
      "additional_notes": "",
      "key_quotes": []
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of identified BRCA1 and BRCA2 variants.",
      "variants_extracted": 6
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 6,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants and penetrance data were extracted successfully."
  }
}